Back
28
Day Range
$187.18
$191.40
52-Week Range
$152.33
$246.33
Volume
552,187
50D / 200D Avg
$207.33
/
$200.41
Prev Close
$185.82
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (626 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | 8.0 | 0.4 |
| P/B | — | 2.9 |
| ROE % | — | 3.8 |
| Net Margin % | 8.6 | 3.9 |
| Rev Growth 5Y % | 8.3 | 10.0 |
| D/E | — | 0.2 |
Key Takeaways
Revenue grew 8.26% annually over 5 years — modest growth
Earnings grew 30.36% over the past year
Generating 849.25M in free cash flow
P/E of 8.03 — trading at a low valuation
PEG of 0.26 suggests growth is underpriced
Capital efficient — spends only 5.85% of revenue on capex
Growth
Revenue Growth (5Y)
8.26%
Revenue (1Y)9.71%
Earnings (1Y)30.36%
FCF Growth (3Y)27.22%
Quality
Return on Equity
N/A
ROICN/A
Net Margin8.57%
Op. Margin11.48%
Safety
Debt / Equity
N/A
Current RatioN/A
Interest Coverage12.68
Valuation
P/E Ratio
8.03
P/B RatioN/A
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 9.71% | Revenue Growth (3Y) | 10.27% |
| Earnings Growth (1Y) | 30.36% | Earnings Growth (3Y) | 44.02% |
| Revenue Growth (5Y) | 8.26% | Earnings Growth (5Y) | 10.69% |
| Profitability | |||
| Revenue (TTM) | 17.36B | Net Income (TTM) | 1.49B |
| ROE | N/A | ROA | N/A |
| Gross Margin | 90.45% | Operating Margin | 11.48% |
| Net Margin | 8.57% | Free Cash Flow (TTM) | 849.25M |
| ROIC | N/A | FCF Growth (3Y) | 27.22% |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | N/A |
| Interest Coverage | 12.68 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | 8.03 | P/B Ratio | N/A |
| P/S Ratio | 0.69 | PEG Ratio | 0.26 |
| EV/EBITDA | N/A | Dividend Yield | 0.00% |
| Market Cap | 11.96B | Enterprise Value | N/A |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 17.36B | 15.83B | 14.28B | 13.40B | 12.64B |
| Net Income | 1.49B | 1.14B | 717.80M | 675.61M | 991.59M |
| EPS (Diluted) | 23.10 | 16.82 | 10.23 | 9.14 | 11.82 |
| Gross Profit | 15.71B | 14.24B | 12.75B | 11.93B | 11.21B |
| Operating Income | 1.99B | 1.68B | 1.18B | 1.00B | 1.36B |
Strategy Scores
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
#384 of 616
Recent Activity
Entered
Price/Sales Ratio Focus (Ken Fisher)
Mar 24, 2026